TLSI
TriSalus Life Sciences, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$5.00
+0.40%Margins
Gross margin
85.8%
EBITDA margin
-48.1%
EBIT margin
-67.7%
Net margin
-62.6%
FCF margin
-66.3%
-430.7%
Return on equity
-45.2%
Return on assets
-74.5%
Return on invested capital
0.68x
Asset turnover
-$29.3M
Cash from operations
$0.75
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026